Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
- PMID: 24659798
- DOI: 10.1136/jnnp-2013-307538
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Keywords: Multiple Sclerosis.
Comment on
-
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1198-208. doi: 10.1136/jnnp-2013-307282. Epub 2014 Mar 21. J Neurol Neurosurg Psychiatry. 2014. PMID: 24659797 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources